Head and Neck Cancer
VTX-2337 for Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (7406)
Phase I Clinical Trial of VTX-2337, a small molecule Toll-Like Receptor 8 (TLR8) agonist in combination with cetuximab in patients with recurrent or metastatic squamous cell carcinomas of the head and neck (SCCHN)
Investigator: Laura Chow; Conditions: Head and Neck Cancer; Status: Recruiting; Study ID: NCT01334177
Phase 2 Study of Pemetrexed in Combination with Carboplatin or Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Investigator: Laura Q.M. Chow, MD; Conditions: Head and Neck Cancer; Status: Recruiting; Study ID: NCT01087970
Join Us On